RevOpsis Therapeutics
Springfield
About RevOpsis Therapeutics
RevOpsis Therapeutics has directed its efforts towards addressing vision loss. By utilizing their exclusive bispecific Surrobody platform, the company aims to target a diverse range of ocular conditions with potential therapeutic agents. The company was founded in 2022 and is based in Springfield, Illinois, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $26.2M
- Funding stage: Seed
- Last round: Seed (Sep 2025)
- Website: revopsis.com
- Phone: 6462215178
Industries & Categories
Health Care, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/revopsis-therapeutics-58100 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.